<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>22(1)</volume><submitter>Qiu X</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>To rethink the clinical significance of standardized uptake values (SUVs) of nasopharyngeal carcinoma (NPC) on &lt;sup>18&lt;/sup>F-fluorodeoxyglucose (&lt;sup>18&lt;/sup>F-FDG) positron-emission tomography (PET).&lt;h4>Methods&lt;/h4>We retrospectively reviewed 369 NPC patients who underwent pretreatment &lt;sup>18&lt;/sup>F-FDG PET. The predictive value of the SUVmax of the primary tumor (SUVmax-t) and regional lymph nodes (SUVmax-n) was evaluated using probability density functions. Receiver operating characteristic curves were used to determine optimal cutoffs for the SUVmax-n/SUVmax-t ratio (NTR). Kaplan-Meier and Cox regression analyses were used to assess survival.&lt;h4>Results&lt;/h4>The optimal SUVmax-t and SUVmax-n cutoffs were 7.5 and 6.9, respectively. High SUVmax-t and SUVmax-n were related to local and regional recurrence, respectively. Patients with low SUVmax had better 3-year overall survival (OS). To avoid cross-sensitization of cutoff points, we stratified patients with high SUVmax into the low and high NTR groups. The 3-year distant metastasis-free survival (DMFS; 92.3 vs. 80.6%, P = 0.009), progression-free survival (PFS; 84.0 vs. 67.7%, P = 0.011), and OS (95.9 vs. 89.2%, P = 0.002) significantly differed between the high vs. low NTR groups for patients with high SUVmax. Multivariable analysis showed that NTR was an independent prognostic factor for DMFS (hazard ratio [HR]: 2.037, 95% CI: 1.039-3.992, P = 0.038), PFS (HR: 1.636, 95% CI: 1.021-2.621, P = 0.041), and OS (HR: 2.543, 95% CI: 1.214-5.325, P = 0.013).&lt;h4>Conclusion&lt;/h4>High SUVmax was associated with NPC recurrence. NTR is a potential prognosticator for DMFS, suggesting that heterogeneity in the pretreatment &lt;sup>18&lt;/sup>F-FDG uptake between the primary tumor and lymph nodes is associated with high invasion and metastatic potential.</pubmed_abstract><journal>BMC cancer</journal><pagination>495</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9069730</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Reflecting on the utility of standardized uptake values on &lt;sup>18&lt;/sup>F-FDG PET in nasopharyngeal carcinoma.</pubmed_title><pmcid>PMC9069730</pmcid><pubmed_authors>Zheng Y</pubmed_authors><pubmed_authors>Huang C</pubmed_authors><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>You Z</pubmed_authors><pubmed_authors>Hu Y</pubmed_authors><pubmed_authors>Liang Z</pubmed_authors><pubmed_authors>Chen C</pubmed_authors><pubmed_authors>Li L</pubmed_authors><pubmed_authors>Fei Z</pubmed_authors><pubmed_authors>Xie S</pubmed_authors><pubmed_authors>Wu H</pubmed_authors><pubmed_authors>Qiu X</pubmed_authors><pubmed_authors>Yi L</pubmed_authors><pubmed_authors>Xu T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Reflecting on the utility of standardized uptake values on &lt;sup>18&lt;/sup>F-FDG PET in nasopharyngeal carcinoma.</name><description>&lt;h4>Background&lt;/h4>To rethink the clinical significance of standardized uptake values (SUVs) of nasopharyngeal carcinoma (NPC) on &lt;sup>18&lt;/sup>F-fluorodeoxyglucose (&lt;sup>18&lt;/sup>F-FDG) positron-emission tomography (PET).&lt;h4>Methods&lt;/h4>We retrospectively reviewed 369 NPC patients who underwent pretreatment &lt;sup>18&lt;/sup>F-FDG PET. The predictive value of the SUVmax of the primary tumor (SUVmax-t) and regional lymph nodes (SUVmax-n) was evaluated using probability density functions. Receiver operating characteristic curves were used to determine optimal cutoffs for the SUVmax-n/SUVmax-t ratio (NTR). Kaplan-Meier and Cox regression analyses were used to assess survival.&lt;h4>Results&lt;/h4>The optimal SUVmax-t and SUVmax-n cutoffs were 7.5 and 6.9, respectively. High SUVmax-t and SUVmax-n were related to local and regional recurrence, respectively. Patients with low SUVmax had better 3-year overall survival (OS). To avoid cross-sensitization of cutoff points, we stratified patients with high SUVmax into the low and high NTR groups. The 3-year distant metastasis-free survival (DMFS; 92.3 vs. 80.6%, P = 0.009), progression-free survival (PFS; 84.0 vs. 67.7%, P = 0.011), and OS (95.9 vs. 89.2%, P = 0.002) significantly differed between the high vs. low NTR groups for patients with high SUVmax. Multivariable analysis showed that NTR was an independent prognostic factor for DMFS (hazard ratio [HR]: 2.037, 95% CI: 1.039-3.992, P = 0.038), PFS (HR: 1.636, 95% CI: 1.021-2.621, P = 0.041), and OS (HR: 2.543, 95% CI: 1.214-5.325, P = 0.013).&lt;h4>Conclusion&lt;/h4>High SUVmax was associated with NPC recurrence. NTR is a potential prognosticator for DMFS, suggesting that heterogeneity in the pretreatment &lt;sup>18&lt;/sup>F-FDG uptake between the primary tumor and lymph nodes is associated with high invasion and metastatic potential.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2026-05-30T20:59:07.436Z</modification><creation>2025-04-04T10:01:50.589Z</creation></dates><accession>S-EPMC9069730</accession><cross_references><pubmed>35513804</pubmed><doi>10.1186/s12885-022-09626-w</doi></cross_references></HashMap>